Background: Cigarette smoking is the best-characterized risk factor for pancreatic cancer. However, data are limited for other tobacco smoking products and smokeless tobacco. Materials and methods: We conducted a pooled analysis of cigar and pipe smoking and smokeless tobacco use and risk of pancreatic cancer using data from 11 case-control studies (6056 cases and 11 338 controls) within the International Pancreatic Cancer Case-Control Consortium (PanC4). Pooled odds ratios (OR) and the corresponding 95% confidence intervals (CI) were estimated by unconditional multiple logistic regression models adjusted for study center and selected covariates. Results: Compared with never tobacco users, the OR for cigar-only smokers was 1.6 (95% CI: 1.2-2.3), i.e. comparable to that of cigarette-only smokers (OR 1.5; 95% CI 1.4-1.6). The OR was 1.1 (95% CI 0.69-1.6) for pipeonly smokers. There was some evidence of increasing risk with increasing amount of cigar smoked per day (OR 1.82 for = 10 grams of tobacco), although not with duration. The OR for ever smokeless tobacco users as compared with never tobacco users was 0.98 (95% CI 0.75-1.3). Conclusion: This collaborative analysis provides evidence that cigar smoking is associated with an excess risk of pancreatic cancer, while no significant association emerged for pipe smoking and smokeless tobacco use. © The Author 2011. Published by Oxford University Press on behalf of the European Society for Medical Oncology. All rights reserved.

Cigar and pipe smoking, smokeless tobacco use and pancreatic cancer: An analysis from the International Pancreatic Cancer Case-Control Consortium (PanC4) / Bertuccio, P.; La Vecchia, C.; Silverman, D.T.; Petersen, G.M.; Bracci, P.M.; Negri, E.; Li, D.; Risch, H.A.; Olson, S.H.; Gallinger, S.; Miller, A.B.; Bueno-de-Mesquita, H.B.; Talamini, R.; Polesel, J.; Ghadirian, P.; Baghurst, P.A.; Zatonski, W.; Fontham, E.T.; Bamlet, W.R.; Holly, E.A.; Lucenteforte, E.; Hassan, M.; Yu, H.; Kurtz, R.C.; Cotterchio, M.; Su, J.; Maisonneuve, P.; Duell, E.J.; Bosetti, C.; Boffetta, P.. - In: ANNALS OF ONCOLOGY. - ISSN 0923-7534. - STAMPA. - 22:6(2011), pp. 1420-1426. [10.1093/annonc/mdq613]

Cigar and pipe smoking, smokeless tobacco use and pancreatic cancer: An analysis from the International Pancreatic Cancer Case-Control Consortium (PanC4)

Negri, E.;Li, D.;Hassan, M.;Boffetta, P.;Silverman, D. T.
2011

Abstract

Background: Cigarette smoking is the best-characterized risk factor for pancreatic cancer. However, data are limited for other tobacco smoking products and smokeless tobacco. Materials and methods: We conducted a pooled analysis of cigar and pipe smoking and smokeless tobacco use and risk of pancreatic cancer using data from 11 case-control studies (6056 cases and 11 338 controls) within the International Pancreatic Cancer Case-Control Consortium (PanC4). Pooled odds ratios (OR) and the corresponding 95% confidence intervals (CI) were estimated by unconditional multiple logistic regression models adjusted for study center and selected covariates. Results: Compared with never tobacco users, the OR for cigar-only smokers was 1.6 (95% CI: 1.2-2.3), i.e. comparable to that of cigarette-only smokers (OR 1.5; 95% CI 1.4-1.6). The OR was 1.1 (95% CI 0.69-1.6) for pipeonly smokers. There was some evidence of increasing risk with increasing amount of cigar smoked per day (OR 1.82 for = 10 grams of tobacco), although not with duration. The OR for ever smokeless tobacco users as compared with never tobacco users was 0.98 (95% CI 0.75-1.3). Conclusion: This collaborative analysis provides evidence that cigar smoking is associated with an excess risk of pancreatic cancer, while no significant association emerged for pipe smoking and smokeless tobacco use. © The Author 2011. Published by Oxford University Press on behalf of the European Society for Medical Oncology. All rights reserved.
2011
Cigar and pipe smoking, smokeless tobacco use and pancreatic cancer: An analysis from the International Pancreatic Cancer Case-Control Consortium (PanC4) / Bertuccio, P.; La Vecchia, C.; Silverman, D.T.; Petersen, G.M.; Bracci, P.M.; Negri, E.; Li, D.; Risch, H.A.; Olson, S.H.; Gallinger, S.; Miller, A.B.; Bueno-de-Mesquita, H.B.; Talamini, R.; Polesel, J.; Ghadirian, P.; Baghurst, P.A.; Zatonski, W.; Fontham, E.T.; Bamlet, W.R.; Holly, E.A.; Lucenteforte, E.; Hassan, M.; Yu, H.; Kurtz, R.C.; Cotterchio, M.; Su, J.; Maisonneuve, P.; Duell, E.J.; Bosetti, C.; Boffetta, P.. - In: ANNALS OF ONCOLOGY. - ISSN 0923-7534. - STAMPA. - 22:6(2011), pp. 1420-1426. [10.1093/annonc/mdq613]
Bertuccio, P.; La Vecchia, C.; Silverman, D.T.; Petersen, G.M.; Bracci, P.M.; Negri, E.; Li, D.; Risch, H.A.; Olson, S.H.; Gallinger, S.; Miller, A.B.; Bueno-de-Mesquita, H.B.; Talamini, R.; Polesel, J.; Ghadirian, P.; Baghurst, P.A.; Zatonski, W.; Fontham, E.T.; Bamlet, W.R.; Holly, E.A.; Lucenteforte, E.; Hassan, M.; Yu, H.; Kurtz, R.C.; Cotterchio, M.; Su, J.; Maisonneuve, P.; Duell, E.J.; Bosetti, C.; Boffetta, P.
File in questo prodotto:
Eventuali allegati, non sono esposti

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11585/682269
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? 25
  • Scopus 66
  • ???jsp.display-item.citation.isi??? 54
social impact